Abstract-Sphingosylphosphorylcholine (SPC) induces differentiation of human adipose tissue-derived mesenchymal stem cells (hADSCs) to smooth muscle cells (SMCs). In the present study, we characterized contractile and ion channel properties of SMCs differentiated from hADSCs (hADSC-SMCs) as a result of SPC treatment, and we investigated the molecular mechanisms involved in the SPC-induced differentiation. Using in vitro collagen gel lattice contraction and whole cell patch clamp, we showed that the hADSC-SMCs expressed functional L-type voltage-gated Ca 2ϩ channels and contractile activities in response to KCl, carbachol, and the L-type Ca 2ϩ channel opener Bay K8644, whereas the L-type Ca 2ϩ channel blocker nifedipine abrogated the contractility of hADSC-SMCs. Furthermore, hADSC-SMCs expressed functional big conductance Ca 2ϩ -activated K ϩ (BK Ca ) channels, and the BK Ca channel blocker iberiotoxin potentiated the Bay K8644-stimulated contractility of the hADSC-SMCs, indicating that these cells exhibited SMC-like contractile characteristics. SPC activated RhoA in hADSCs and pretreatment with the Rho kinase inhibitor Y27632 or by overexpression of dominant-negative mutants of RhoA or Rho kinase completely abrogated the SPC-induced differentiation of hADSCs into SMCs. SPC also increased the expression levels of myocardin-related transcription factor (MRTF)-A, a transcription factor involved in smooth muscle differentiation, in hADSCs. Small interference RNA-mediated depletion of endogenous MRTF-A abolished the SPC-induced differentiation of hADSCs into SMCs. 
S mooth muscle cells (SMCs) play important roles in angiogenesis, blood vessel maintenance, and blood pressure regulation. SMCs exhibit a contractile phenotype characterized by high expression of specific contractile proteins including ␣-smooth muscle actin (␣-SMA), calponin, SM22␣, smoothelin, h-caldesmon, and smooth musclemyosin heavy chain (SM-MHC). 1, 2 The phenotypic SMC expression pattern has been implicated not only in vascular development but also in cardiovascular diseases like hypertension and atherosclerosis. 2, 3 A variety of ion channels regulate SMC contractility; among them are the voltagedependent L-type Ca 2ϩ channels and the big conductance Ca 2ϩ -activated K ϩ (BK Ca ) channels. 4, 5 Although SMC differentiation is an essential component of vascular development, little is known about the specific factors and molecular mechanisms that designate stem cells to differentiate into functional SMCs that express a SMC-specific set of contractile proteins and ion channels.
An increasing body of evidence demonstrates that transcription of smooth muscle-specific genes is mediated by serum response factor (SRF) and myocardin family of SRF cofactors, ie, myocardin, myocardin-related transcription factor (MRTF)-A (or MKL1), and MRTF-B (or MKL2). 2, 6, 7 SRF regulates SMC-specific transcription by binding to the CArG boxes found in the promoters of nearly all of SMC marker genes. Myocardin, in turn, constitutively activates SRFdependent transcription. 8 -11 In unstimulated cells, MRTF-A/B are sequestered in the cytoplasm through direct interaction with G-actin, but RhoA/Rho kinase-mediated actin polymerization depletes the G-actin pool, which frees MRTF from G-actin to enter the nucleus where it can stimulate SRF-dependent transcription of SMC-specific genes. 12 Therefore, these results suggest that the RhoA/Rho kinase pathway plays a key role in SMC differentiation by regulating the integrity of the cytoskeleton and the cellular locale of MRTF. 13, 14 Mesenchymal stem cells (MSCs) can be isolated from a variety of tissues, such as bone marrow, periosteum, trabecular bone, synovium, skeletal muscle, deciduous teeth, and adipose tissues, and they exhibit self-renewal and long-term viability, as well as the potential to differentiate along adipogenic, osteogenic, chondrogenic, or myogenic lineages. [15] [16] [17] [18] In vitro, MSCs differentiate into SMCs in response to transforming growth factor (TGF)-␤, 19, 20 mechanical stress, 21 and direct contact with vascular endothelial cells. 22 Moreover, adoptively transferred MSCs differentiate into SMCs and contribute to the remodeling of vasculature in vivo. [23] [24] [25] The ability of MSCs to generate SMCs makes them an ideal model to study de novo generation of SMCs, and it renders them useful in other applications as well, including tissue engineering. It has been reported that human adipose tissue-derived MSCs (hADSCs) have similar expression profiles and differentiation potential to human bone marrow-derived MSCs. 26 Therefore, hADSCs are highly useful for the study of de novo generation of SMCs and vascular tissue engineering for clinical application.
Sphingosylphosphorylcholine (SPC) is a sphingolipid generated by N-deacylation of sphingomyelin, among the most abundant lipids in the cell membrane. SPC enhances Ca 2ϩ sensitization, and it thereby induces contraction of a variety of smooth muscle tissues, including gastrointestinal smooth muscle, mesenteric microvessels, and coronary and cerebral arteries. 27, 28 In a previous study, we demonstrated that SPC induced differentiation of hADSCs into smooth muscle-like cells and that small interference siRNA-mediated depletion of endogenous SRF and myocardin attenuated the SPC-induced expression of SMC markers. 29 These observations suggest that SRF and myocardin are an essential components of SPC-induced differentiation of hADSCs into SMCs, but no known studies have addressed whether the differentiated SMCs exhibit smooth muscle-like contractile responses or whether the RhoA/Rho kinase/MRTF pathway is involved in this SPC-induced differentiation process. In the present study, we demonstrated for the first time that SPC induced differentiation of MSCs to contractile SMCs by activating the RhoA/Rho kinase/MRTF-dependent pathway.
Materials and Methods
hADSCs were isolated from human subcutaneous adipose tissue and cultured in growth medium (␣-minimum essential medium supplemented with 10% FBS, 100 U/mL penicillin, and 100 g/mL streptomycin). The collagen gel lattice contraction assay was performed as previously described 30 
Results

SMCs Differentiated From hADSCs by SPC Treatment Exhibited Increased Contractility
Treating of hADSCs with 2 mol/L SPC for 4 days elicited their differentiation into SMCs, as demonstrated by their increased expression of the SMC-specific transcription factor myocardin and the following SMC-specific contractile proteins: ␣-SMA, calponin, h-caldesmon, smoothelin, and SM-MHC ( Figure I in the online data supplement). In humans, 2 isoforms have been described: smoothelin-A (59 kDa), which is predominantly expressed in visceral SMC, and smoothelin-B (100 kDa), which is found in vascular SMC (van Eys et al, 1997). In the present study, an Ϸ100-kDa protein band was recognized by Western blotting with antismoothelin antibody, suggesting SPC-induced expression of smoothelin-B in hADSCs. To explore whether SMCs differentiated from hADSCs (hADSC-SMCs) as a result of SPC treatment were capable of contracting and generating force, we measured the contractile ability of the cells by using collagen lattice contraction assay. In this assay, SMCs that are embedded in attached collagen matrices generate isometric tension, and releasing the collagen lattice from the culture dish causes mechanical unloading and contraction as the actin cytoskeleton of the embedded cells becomes free to contract the deformable collagen lattice. 31 We reconstituted either hADSC-SMCs or undifferentiated hADSCs (where indicated) into these collagen lattices, and we allowed the embedded cells to shrink the floating lattices by incubating them with serum-free medium at 37°C for the indicated time periods. As shown in Figure 1A and 1B, incorporation of hADSC-SMCs time-dependently reduced the size of the collagen lattices, indicating basal contractile tone. However, the collagen lattices containing undifferentiated hADSCs contracted to a lesser extent than those containing hADSC-SMCs.
Because membrane depolarization and contractile agonists regulate SMC contractility, 32 we evaluated whether these factors affects the contractility of hADSC-SMCs by measuring the effects of KCl and carbachol on the contraction of collagen lattices containing hADSC-SMCs. As shown in Figure 1C , exposure of the collagen lattices containing hADSC-SMCs to either 60 mmol/L KCl or 1 mol/L carbachol enhanced their shrinkage. However, collagen gel lattices harboring undifferentiated hADSCs did not contract in response to KCl or carbachol. These results suggest that hADSC-SMCs exhibited contractility in response to membrane depolarization or contractile stimuli.
L-Type Ca 2؉ Channels Play a Role in hADSC-SMCs Contraction
Contraction of SMCs stems from membrane depolarization and an increase in Ca 2ϩ influx mediated by voltage-gated L-type Ca 2ϩ channels. 33 To explore whether L-type Ca 2ϩ channels were involved in the contractility of hADSC-SMCs, we examined their expression level of Cav 1.2 , a smooth muscle-specific L-type Ca 2ϩ channel isoform. 34 As shown in Figure 2A , treating hADSCs with 2 mol/L SPC for 4 days markedly increased their Cav 1.2 expression levels. To functionally correlate this expression of L-type Ca 2ϩ channel to a Ca 2ϩ current, we recorded the Ba 2ϩ -sensitive and voltagedependent Ca 2ϩ currents in the hADSC-SMCs using Bay K8644, an L-type Ca 2ϩ channel opener, in perforated patchclamp assays. As shown in Figure 2B and 2C, the hADSCSMCs exhibited Ba 2ϩ -sensitive inward current in the presence of Bay K8644, in contrast to the lack of a significant current in undifferentiated hADSCs, suggesting that L-type Ca 2ϩ channels are highly expressed in hADSC-SMCs.
To explore whether L-type Ca 2ϩ channel-mediated Ca 2ϩ influx is involved in the contractile response of the hADSCSMCs, we determined the effect of Bay K8644 on the contraction of collagen lattices embedded with hADSCSMCs or undifferentiated hADSCs. As shown in Figure 2D , Bay K8644 stimulated contraction of the collagen lattices containing hADSC-SMCs, whereas it had no significant impact on the contraction of the collagen lattices containing undifferentiated hADSCs. Furthermore, treating the collagen by Student's t test. D, Collagen gel lattices embedded with hADSC-SMCs or hADSCs were exposed to serum-free medium containing 10 mol/L Bay K8644 or a vehicle (w/o), and gel contraction was photographed at the indicated time using a digital camera. The relative lattice area was obtained by dividing the area at each time point by the initial area of the lattice. Data represent meansϮSD (nϭ4). *PϽ0.05 vs respective controls (0 hour), #PϽ0.05; 2-way ANOVA and Scheffe's post hoc test. E, Collagen gel lattices embedded with hADSC-SMCs or hADSCs were exposed to serum-free medium containing 10 mol/L Bay K8644 or a vehicle in the absence or presence of 10 mol/L nifedipine for 24 hours, and gel contraction was photographed using a digital camera. The relative lattice area was obtained by dividing the area at 24 hours by the initial area of the lattice. Data represent meansϮSD (nϭ5). *PϽ0.05 vs respective controls, #PϽ0.05; 2-way ANOVA and Scheffe's post hoc test. lattices with nifedipine (an L-type Ca 2ϩ channel blocker) during the contraction assay completely abrogated the basal and Bay K8644 -stimulated contractile responses ( Figure 2E ). Taken together, these results suggest that SPC increased the expression of L-type Ca 2ϩ channels and that these channels are responsible for the contractile response induced by membrane depolarization.
L-Type Ca 2؉ Channels Were Involved in the Membrane Depolarization-Induced Contractility of hADSCs
We next explored whether the L-type Ca 2ϩ channel-mediated Ca 2ϩ influx was involved in the membrane depolarizationinduced contractility of hADSC-SMCs. As shown in supplemental Figure IIA , treating the cells with 60 mmol/L KCl increased their intracellular Ca 2ϩ concentration, but it had no effect on undifferentiated hADSCs. Moreover, pretreating the hADSC-SMCs with 10 mol/L nifedipine completely abrogated not only the KCl-induced elevation of intracellular Ca 2ϩ concentration but also hADSC-SMC contractility (supplemental Figure IIB) . These results suggest that membrane depolarization stimulated hADSC-SMC contractility by enhancing Ca 2ϩ influx through their L-type Ca 2ϩ channels. from the cytoplasm. 35 To explore the involvement of BK Ca channels in the contractile response of hADSC-SMCs, we examined their BK Ca channel expression level by Western blotting. As shown in Figure 3A , BK Ca channel expression was higher in hADSC-SMCs than in undifferentiated hADSCs. To further confirm that these BK Ca channels were functional in hADSC-SMCs, we measured BK Ca channel activity in a whole cell configuration. Figure 3B shows that depolarizing voltage steps from -80 to 60 mV generated BK Ca currents, identified as such because they were sensitive to iberiotoxin, a specific BK Ca inhibitor. The amplitude of the outward currents in the hADSC-SMCs was substantial throughout the entire voltage range, in contrast to the constitutively low BK Ca current in undifferentiated hADSCs ( Figure   3B and 3C). Together with the increased expression of BK Ca in the hADSC-SMCs, these results suggest that functional BK Ca channels are upregulated in hADSC-SMCs.
To delineate the involvement of BK Ca in SMC contraction, we determined the effect of iberiotoxin on the contractile ability of the hADSC-SMCs. As shown in Figure 3D , iberiotoxin potentiated the Bay K8644-induced contraction of collagen lattices containing hADSC-SMCs. Therefore, it is likely that pharmacological inhibition of BK Ca amplified the contraction induced by L-type Ca 2ϩ channel opening, because it prevented membrane potential repolarization.
SPC Induced SMC Differentiation of hADSCs Through a RhoA/Rho Kinase-Dependent Mechanism
Accumulating evidence suggests that RhoA-mediated rearrangement of the actin cytoskeleton plays a pivotal role in SMC differentiation. 14 To explore whether SPC activated RhoA in hADSCs, we treated the cells with SPC and measured the resulting GTP-loaded RhoA levels with a RhoA activation assay. As shown in Figure 4A , we could detect GTP-RhoA as early as 2 minutes following SPC treatment, after which GTP-RhoA levels were maximally increased at 5 minutes. To elucidate whether RhoA activation participated in the SPC-induced differentiation of hADSCs into SMCs, we examined the effect of a dominant-negative RhoA mutant (RhoA N19 ) on expression of SMC-specific markers in response to SPC. As shown in Figure 4B , ectopic overexpression of RhoA N19 inhibited the SPC-induced expression of ␣-SMA, suggesting that RhoA plays a key role in the SPC-induced differentiation of hADSCs into SMCs.
To explore whether RhoA operated through one of its major downstream targets, Rho kinase, to mediate the SPCinduced differentiation of hADSCs to SMCs, we examined whether we could inhibit this differentiation with Y27632, a Rho kinase-specific inhibitor. As shown in Figure 4C , pretreating cells with Y27632 abrogated their SPC-induced expression of the SMC-specific markers, including ␣-SMA, calponin, SM-MHC, smoothelin, h-caldesmon, and myocardin. To confirm these results, we examined the effect of RB/PH (TT), a dominant-negative mutant of Rho kinase, 36 on the SPC-induced ␣-SMA expression in hADSCs. As shown in Figure 4D , overexpression of the RB/PH (TT) abrogated the SPC-stimulated expression of ␣-SMA, suggesting a key role of Rho kinase in the SPC-induced differentiation of hADSCs to SMCs.
To support the notion that Rho kinase is involved in SPC-induced differentiation of hADSCs to SMCs, we next examined whether the SPC-induced expression and intracellular localization of ␣-SMA was influenced by Y27632. As shown in supplemental Figure III , treating hADSCs with 2 mol/L SPC for 4 days increased their expression of ␣-SMA, which localized to F-actin filaments. The increased assembly of actin filaments and thick fiber formation in response to SPC correlated strongly with the increased ␣-SMA expression, whereas pretreating the cells with Y27632 completely blocked ␣-SMA expression and actin polymerization induced by SPC. These results suggest that Rho kinase is crucial for SPC-induced expression of ␣-SMA and actin polymerization in hADSCs.
Rho Kinase Was Essential for SPC-Induced Contractility
To explore whether Rho kinase-mediated expression of contractile proteins is responsible for the increased contractility, we treated hADSCs with SPC in the absence or presence of Y27632 for 4 days, after which we examined their contractility. Consistent with the result that Y27632 abrogated the expression of ␣-SMA in hADSCs, pretreatment with Y27632 also completely abrogated SPC-induced contractility (supplemental Figure IV) . Therefore, these results suggest that Rho kinase stimulates expression of contractile proteins in SPC-differentiated hADSC-SMCs to promote their increased contractility.
MRTF-A Is Critical for SPC-Induced Differentiation of hADSCs to SMCs
Recent reports suggest that the transcription factor SRF and its cofactors (myocardin, MRTF-A, and MRTF-B) regulate expression of smooth muscle-specific genes. 2, 6, 7 We previously demonstrated that SPC treatment increases expression levels of SRF and myocardin and that siRNA-mediated depletion of SRF or myocardin abrogated the SPC-induced expression of ␣-SMA. 29 To explore the effects of SPC on the expression of MRTF isoforms, we measured the mRNA levels of myocardin and MRTF isoforms after SPC treatment. As shown in Figure 5A and 5B, SPC treatment significantly increased the expression levels of myocardin and MRTF-A, but not of MRTF-B, suggesting that myocardin and MRTF-A may be associated with the SPC-induced differentiation of hADSCs to SMCs.
To clarify whether MRTF-A is involved in this differentiation process, we examined the effects of siRNA-mediated MRTF-A depletion on SPC-induced expression of SMCspecific markers. Transfection of hADSCs with an MRTFspecific siRNA attenuated endogenous MRTF-A expression ( Figure 5C ), which significantly inhibited SPC-induced expression of ␣-SMA, calponin, SM-MHC, h-caldesmon, smoothelin, and myocardin ( Figure 5D ). These results suggest that MRTF-A plays a key role in the SPC-induced differentiation of hADSCs to SMCs.
According to previous studies, MRTF localizes to the cytoplasm in unstimulated cells and RhoA/Rho kinasemediated actin polymerization elicits translocation of MRTF to the nucleus, where it promotes transcription of SMC-specific genes. 12, 37 To explore whether SPC induced translocation of MRTF-A through a Rho kinase-dependent mechanism, we determined the intracellular localization of FLAG-tagged MRTF-A in response to SPC treatment. As shown in Figure 6 , MRTF-A was largely cytoplasmic in serumstarved hADSCs, but SPC treatment led to translocation of MRTF-A to the nucleus. This translocation was inhibitable by pretreating the cells with Y27632. These results suggest that SPC induced differentiation of hADSCs to SMCs through Rho kinase-dependent nuclear translocation of MRTF-A.
Discussion
SMCs express ion channels that are responsible for their contractile activity. Specifically, the contractile process involves voltage-dependent Ca 2ϩ channel-mediated Ca 2ϩ influx, Ca 2ϩ /calmodulin-dependent contraction, and K ϩ channel-mediated repolarization of membrane potential. 4, 5 In the present study, we demonstrated for the first time that SPC induced differentiation of hADSCs to functional SMCs. First, hADSC-SMCs expressed SMC-specific contractile proteins and ion channels, including L-type Ca 2ϩ and BK Ca channels. Second, hADSC-SMCs exhibited contractility in response to the L-type Ca 2ϩ channel opener Bay K8644 and membrane depolarization induced by KCl, and the L-type Ca 2ϩ channel blocker nifedipine blocked the contractile responses. Third, the BK Ca channel blocker iberiotoxin potentiated the Bay K8644 -induced contractile activity of hADSC-SMCs, presumably because it inhibited repolarization. In support of the present study, it was recently reported that TGF-␤1 induced differentiation of bone marrow-derived multipotent adult progenitor cells into functional SMCs. These cells expressed functional L-type Ca 2ϩ channels and exhibited a contractile reaction in response to KCl, the L-type Ca 2ϩ channel opener FPL64176, serotonin, and endothelin-1. 38 In addition, functional SMCs could be isolated from transgenic embryonic stem cell lines that stably expressed a puromycinresistance gene under the control of either ␣-SMA or SM-MHC promoter. 39 These SMCs displayed agonist-induced Ca 2ϩ transients and expressed functional Ca 2ϩ channels; moreover, they generated a contractile force within collagen gels in response to endothelin-1 or membrane depolarization. hADSCs have a clinical advantage as progenitors of functional SMCs because large amounts of hADSCs can easily be isolated from patient adipose tissues. Therefore, these results led us to suggest that SPC-induced differentiation of hADSCs into functional SMCs would be highly useful for vascular tissue engineering.
In the present study, we demonstrated that blocking the RhoA/Rho kinase pathway, either by overexpressing dominant-negative RhoA (DN-RhoA) or Rho kinase (DNRho kinase) constructs or by pretreating cells with Y27632, completely abrogated the SPC-induced expression of SMCspecific markers. Consistent with these results, an increasing body of evidence demonstrates a key role for RhoAdependent signaling in the expression of smooth musclespecific genes in a variety of cell types: Inhibition of RhoA by C3 exoenzyme or DN-RhoA or pharmacological inhibition of Rho kinase with Y27632 abrogated TGF-␤1-induced expression of ␣-SMA in Monc-1 neural crest stem cells. 40 Sphingosine-1-phosphate increased RhoA activity and ␣-SMA expression in SMCs, and inhibition of Rho kinase by Y27632 attenuated this sphingosine-1-phosphate-stimulated ␣-SMA expression. 41 Furthermore, inhibiting Rho kinase activity with Y27632 abrogated the renal fibrosis-associated increase in ␣-SMA expression 42 and TGF-␤1-induced ␣-SMA expression in gingival fibroblasts. 43 These results support the notion that the RhoA/Rho kinase signaling pathway plays a key role in the SPC-induced differentiation of hADSCs to SMCs.
In the present study, we demonstrated that SPC treatment promoted MRTF-A expression and that knockdown of en- dogenous MRTF-A expression abrogated the SPC-induced differentiation of hADSCs to SMCs. Furthermore, SPC induced translocation of MRTF-A from the cytosol to the nucleus through a Rho kinase-dependent mechanism. Activation of RhoA has been reported to induce actin polymerization through the ROCK/LIM kinase (LIMK)/cofilin pathway, which stabilizes F-actin and mDia1 and promotes the assembly of monomeric G-actin into F-actin filaments. 44, 45 Actin polymerization resulted in the translocation of MRTF-A from the cytoplasm to the nucleus. 12, 46, 47 Pharmacological inhibition of Rho kinase with Y27632 abrogated nuclear translocation of MRTF-A induced by sphingosine-1-phosphate or mechanical force. 48, 49 Therefore, it is likely that MRTF-A is a key factor in transducing Rho/actin signaling from the cytoplasm to the nucleus and in activating transcription of SMC-specific genes in response to SPC treatment. In addition, we demonstrated that either knockdown of endogenous MRTF-A or pharmacological inhibition of Rho kinase attenuated the SPC-induced expression of myocardin. Taken together with the previous report that myocardin plays a key role in the SPC-induced expression of SMC-specific markers in hADSCs, 29 these results suggest that Rho kinase-dependent activation of MRTF-A appears to act upstream of the myocardin pathway during SMC differentiation of hADSCs.
The physiological and pathophysiological significance of MSCs in cardiovascular development and diseases is still unclear, attributable to a lack of precise knowledge regarding their anatomic distribution within tissues. However, several lines of evidence suggest that vascular pericytes or solitary SMCs, which are progenitors of SMCs involved in blood vessel formation, have phenotypic and physiological characteristics similar to MSCs. 18 Similar to MSCs, pericytes possess adipogenic, osteogenic, and chondrogenic differentiation potential. 50, 51 The present study, together with these earlier studies, suggest that MSCs may be SMC progenitors within local tissue and that SPC may promote angiogenesis and vasculogenesis by inducing differentiation of MSCs to SMCs.
